is a rare autosomal recessively inherited disorder, characterized by hypophosphatemia, short stature, rickets and/or osteomalacia, and secondary absorptive hypercalciuria. HHRH is caused by a defect in the sodiumdependent phosphate transporter (NaPi-IIc/Npt2c/NPT2c), which was thought to have only a minor role in renal phosphate (Pi) reabsorption in adult mice. In fact, mice that are null for Npt2c (Npt2c Ϫ/Ϫ ) show no evidence for renal phosphate wasting when maintained on a diet with a normal phosphate content. To obtain insights and the relative importance of Npt2a and Npt2c, we now studied Npt2a
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Ϫ/Ϫ double-knockout (DKO). DKO mice exhibited severe hypophosphatemia, hypercalciuria, and rickets. These findings are different from those in Npt2a KO mice that show only a mild phosphate and bone phenotype that improve over time and from the findings in Npt2c KO mice that show no apparent abnormality in the regulation of phosphate homeostasis. Because of the nonreddundant roles of Npt2a and Npt2c, DKO animals showed a more pronounced reduction in Pi transport activity in the brush-border membrane of renal tubular cells than that in the mice with the single-gene ablations. A high-Pi diet after weaning rescued plasma phosphate levels and the bone phenotype in DKO mice. Our findings thus showed in mice that Npt2a and Npt2c have independent roles in the regulation of plasma Pi and bone mineralization.
hereditary hypophosphatemic rickets; bone mineralization THE KIDNEY IS A MAJOR regulator of phosphate (P i ) homeostasis and has the P i reabsorptive capacity to accommodate physiologic P i requirement. Up to 70% of filtered P i is reabsorbed in the proximal tubule where sodium-dependent P i transport systems in the brush-border membrane (BBM) mediate the ratelimiting step in the overall P i reabsorptive process (3, 12, 13, 21) . P i transport across the apical membrane is mediated by the three members of the SLC34 family (SLC34A1-A3) of solute carriers (3, 12, 13, 21) . Expression of SLC34A1 (NaPi-IIa/ NPT2a) and SLC34A3 (NaPi-IIc/NPT2c) is restricted to the BBM of renal proximal tubules, at least in rodents where their mRNA and protein levels could be readily assessed (3, 12, 21) .
In rats and mice, Npt2a has the most important role in renal P i reabsorption (70 -80%), while Npt2c was thought to have the most important regulatory role around weanling animals (3, 12, 17, 21) . In adult animals, maintained on a normal phosphate diet, however, Npt2c mediates only a very small percentage of P i reabsorption (3, 12, 17, 21) .
These findings in rodents were surprising, since humans affected by hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a rare autosomal recessively inherited disorder that is caused by homozygous or compound heterozygous mutations in NPT2c, usually present with hypophosphatemia due to renal phosphate-wasting, short stature, rickets and/or osteomalacia, and secondary absorptive hypercalciuria (2, 7, 10, 11, 25) . These observations suggest that the NPT2c cotransporter has, at least in humans, an important role in renal P i reabsorption and bone mineralization and may be a key determinant of plasma P i concentrations in human (2, 7, 10, 11, 25) . However, the serum and urinary findings in humans affected by HHRH can be quite variable, indicating that dietary or environmental factors, and/or additional genetic variations, significantly contribute to the severity of the disease (24) .
In the present study, we generated mice that are null for Npt2a Ϫ/Ϫ Npt2c Ϫ/Ϫ double knockout (DKO) mice and compared the findings with those observed in mice that are null for either Npt2a or Npt2c alone. The laboratory and bone abnormalities were more profound in the DKO mice than in animals with ablation of only one transporter, indicating that both molecules have similarly nonredundant roles in phosphate homeostasis in rodents and humans.
MATERIALS AND METHODS
Mice. Male C57BL/6 mice were purchased from Charles River Laboratories Japan (Yokohama, Japan). Male and female Npt2a ϩ/Ϫ mice were purchased from Jackson Laboratory (Bar Harbor, ME) (1). Crossing male and female Npt2a ϩ/Ϫ mice yielded Npt2a Ϫ/Ϫ mice. Npt2c-deficient mice were generated by gene targeting (19) . Briefly, a targeting vector was constructed by replacing the genomic Npt2c locus (exon 3 to exon 5) with the neomycin resistance gene (neo r ) (19) . Crossing male and female Npt2c ϩ/Ϫ mice yielded Npt2c
mice. Mice were maintained under pathogen-free conditions and handled in accordance with the Guidelines for Animal Experimentation of the Tokushima University School of Medicine, and all animal experiments were approved by the Tokushima University Animal Experiment Committee.
Generation of Npt2a
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).
Background of both Npt2a
Ϫ/Ϫ and Npt2c Ϫ/Ϫ mice is C57BL/6J. Successive crosses of these mice yielded Npt2a
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Ϫ/Ϫ (DKO) mice. Plasma, urinary, and bone parameters were studied in four genotypes:
Ϫ/Ϫ mice. Genotyping. Mice were genotyped by PCR amplification of genomic DNA. PCR typing of genomic DNA was performed by using Ampdirect (SHIMADZU, Kyoto, Japan). PCR primers used to genotype the Npt2c gene ablation were as follows: primer 1 (5Ј-ctcaccatacatgcag-3Ј), primer 2 (5Ј-ctgcatttctcagactccgg-3Ј), and primer 3 (5Ј-cggtatcgccgctcccgatc-3Ј) (19) . PCR primers used to genotype the Npt2a gene ablation were as follows: sense primer 1 (5Ј-TGCCCAGGTTGGCAC-GAAGC-3Ј), primer 2 (5Ј-AGTCCTGTCCCTGCCTGCA-3Ј), and primer 3 (5Ј-TGCTACTTCCATTTGTCACGTCC-3Ј) (1). DKO mice using primers (Npt2a and Npt2c) used primers described above.
Plasma and urine parameters. Concentrations of plasma and urinary inorganic calcium (Ca) and P i were determined using the Calcium-E test (Wako, Osaka, Japan) and the Phospha-C test (Wako), respectively (19) . The concentration of urinary creatinine (Cr) was determined using the Creatinine-wako test (Wako). Concentrations of plasma PTH were determined using the PTH enzyme-linked immunosorbent assay kit (Immunotopics, San Clemente, CA) (19) . Concentrations of plasma 1,25-dihydroxyvitamin D 3 [1,25(OH)2D3] were determined by a radioreceptor assay (SRL, Tokyo, Japan). Concentrations of plasma fibroblast growth factor (FGF)-23 protein were determined using the FGF-23 enzyme-linked immunosorbent assay kit (KAINOS Laboratories, Tokyo, Japan) (19) . Metabolic cages were used for 24-h urine collection. The fractional excretion index for P i (FEI Pi) and for Ca (FEI Ca) were calculated as urine Pi or Ca/(urine creatinine ϫ plasma Pi or Ca) (1) .
Preparation of membrane fraction and transport assay. BBM vesicles (BBMVs) were prepared from mouse kidneys using the Ca 2ϩ precipitation method, as described previously (19, 27) . The levels of alkaline phosphatase in whole homogenates and BBMVs were measured to assess the purity of the membranes (5). The transport rate of phosphate into renal BBMV was determined at 30 s, 60 s, and 60 min (equilibrium value) at 25°C inward gradient of 100 mM NaCl 2 or 100 mM KCl and 0.1 mM KH2PO4 (pH 7.5). All measurements were performed in triplicates. Uptake of [ 14 C]leucine was performed as an internal control. Immunoblotting analysis. Protein samples were heated at 95°C for 5 min in sample buffer in the presence of 2-mercaptoethanol and then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The separated proteins were transferred by electrophoresis to a polyvinylidene difluoride transfer membrane (Imobilon-P, Millipore, MA) and then incubated with diluted antibodies as follows: affinitypurified anti-Npt2a COOH-terminal (1:10,000) and Npt2c COOHterminal (1:2,000) Na/Pi transporter antibodies (16) . Horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG was utilized as the secondary antibody (Jackson Immuno Research Laboratories) and signals were detected using the Immobilon Western Chemiluminescent HRP Substrate (Millipore).
Von Kossa's staining for the kidney. Von Kossa staining for mineral deposition in the kidney was performed by applying 5% silver nitrate to the renal sections and exposing the sections to bright light for 30 min (4). Sections were counterstained for tissue and cell morphology using hematoxylin for paraffin sections.
Bone tissue preparation and bone analysis. Wild-type mice and DKO mice at 4 and 12 wk of age were perfused with 4% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4) through the left cardiac ventricle. Femora and tibiae were removed and immersed in the same fixative for an additional 12 h at 4°C. Mouse bone sections for hematoxylin and eosin staining and Von Kossa staining were performed as described previously (15) . Briefly, undecalcified semithin epoxy resin sections were incubated with an aqueous solution of 5% silver nitrate (Wako Pure Chemical Industries) for 60 min at room temperature under sunlight until they turned a dark brown color. Following a rinse in distilled water, the sections were incubated with a 5% sodium thiosulfate solution (Wako) for 5 min. The sections were faintly stained with toluidine blue (15) .
For bone histomorphometry, all mice were injected with calcein (8 mg/kg body wt, Wako, Osaka, Japan) (9, 26) . For Villanueva-Goldner staining, the right tibiae (DKO mice at 8 wk of age) were excised, fixed with 70% ethanol, embedded in methyl methacrylate, and sectioned in 6-m slices (9, 26) .
Statistical analysis. Data are expressed as means Ϯ SD. Differences among multiple groups were analyzed by ANOVA. A P Ͻ 0.05 was considered statistically significant.
RESULTS

Generation of Npt2a
Ϫ/Ϫ Npt2 Ϫ/Ϫ (DKO) mice. Body weight analysis (Fig. 1, A and B 
Npt2c
Ϫ/Ϫ mice. Furthermore, the body weight of Npt2a KO mice was significantly reduced at birth and at 12 wk compared with the WT and Npt2a
Ϫ/Ϫ mice. Marked growth retardation was also observed in DKO mice (Fig.  1, A and B) . From 8 to 13 wk after birth, the body weight of DKO mice gradually increased, but DKO mice remained the lightest of all groups (Fig. 1B) . The body weight of Npt2a
Ϫ/Ϫ mice was similar to WT mice (Fig. 1B) .
Western blotting analysis of renal BBM proteins also demonstrated the absence of detectable Npt2a in Npt2a Ϫ/Ϫ mice and detectable Npt2c in Npt2a (Fig. 1C) . Renal Npt2c protein levels were significantly increased in Npt2a KO mice compared with WT mice (Fig. 1C, top) . In contrast, renal Npt2a protein levels were similar when comparing WT mice and Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice (Fig. 1C, middle) . In DKO mice, neither Npt2a nor Npt2c protein was detected (Fig. 1C) . Furthermore, immunohistochemical analysis failed to detect any signals for Npt2a and Npt2c in tissue slices from DKO mice (data not shown). Renal Na ϩ -dependent P i transport activity in the BBMVs was significantly lower in Npt2a KO mice than in WT or Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice (Fig.  1D) . Furthermore, Na ϩ -dependent P i transport activity was lower in DKO mice than in Npt2a KO mice. However, at equilibrium (90 min), when the Na ϩ gradient has dissipated, P i uptake is comparable in all groups of mice (data not shown). There were no differences in Na ϩ -independent P i transport activity between mouse groups (data not shown). Moreover, the Na ϩ -dependent and -independent L-leucine uptake, measured in parallel, were also similar in all genotypes (WT, DKO, Npt2a KO, and Npt2a Plasma and urine parameters in DKO mice. Npt2a KO mice show hypophosphatemia, renal P i wasting, increased plasma 1,25(OH) 2 D 3 levels, and hypercalciuria at weaning, but the magnitude of these changes decreases with increasing age (1). In adult Npt2a KO mice, there is a dramatic reversal and eventual over compensation of the skeletal phenotype (1). Therefore, we investigated plasma and urine parameters in DKO at 12 wk old. Npt2a KO mice but not Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice displayed hypophosphatemia and hypercalcemia (Fig. 2,  A and B) (1). The DKO mice had severe hypophosphatemia and hypercalcemia (Fig. 2, A and B) . Npt2a KO mice and Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice had higher levels of 1,25(OH) 2 D 3 compared with WT mice. In addition, the DKO mice had the highest levels of plasma 1,25(OH) 2 D 3 compared with other groups (Fig. 2C) . Plasma PTH levels were significantly decreased in Npt2a KO and DKO mice compared with WT mice and Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice (Fig. 2D) . Plasma FGF23 levels were significantly decreased in Npt2a
, Npt2a KO, and DKO mice (Fig. 2E) . In addition, DKO mice had significantly lower levels of plasma FGF23 compared with Npt2a
and Npt2a KO mice. Npt2a KO mice but not Npt2a
mice had hyperphosphaturia (Fig. 2, F and H) . In contrast, urinary Ca excretion levels were significantly increased in Npt2a KO mice and Npt2a
Ϫ/Ϫ mice compared with WT mice (Fig.  2, G and I) . In DKO mice, the urine P i to Cr ratio (P i /Cr) was significantly increased in comparison with WT and Npt2a
Ϫ/Ϫ mice (Fig. 2F) . The FEI P i was significantly higher in DKO mice than other groups (Fig. 2H) . Both urine Ca-to-Cr ratio (Ca/Cr) and FEI Ca were significantly higher in DKO mice than in other groups (Fig. 2, G and I) . Renal stone formation in DKO mice. HHRH is characterized by increased serum 1,25(OH) 2 D 3 concentration, resulting in secondary absorptive hypercalciuria and associated renal calcification and renal stone disease (10) . Therefore, we investigated mineral deposits in the kidneys of WT, Npt2a KO, Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ , and DKO mice (Fig. 3) . Von Kossa staining of renal sections demonstrated the presence of mineral deposits in kidneys of 12-wk-old Npt2a KO mice, as described previously (Fig. 3B) (4) . In the WT and Npt2a
mice, no obvious mineral deposits were detected (Fig. 3, A and  C) . DKO mice showed marked calcium deposits in the tubules compared with Npt2a KO mice (Fig. 3, B and D) . At all locations in the kidney (cortex, medulla, and papilla) of DKO mice, calcium deposits were detected (Fig. 3, E and F) .
Bone analysis in DKO mice. In comparison with WT mice, DKO mice developed the typical features of rickets, including deeper growth plate cartilage, especially expansion of the hypertrophic zone, and irregularly arranged metaphyseal trabecules (Fig. 4, IA-ID) . Furthermore, von Kossa staining verified markedly reduced mineralization in DKO trabecules and well-mineralized matrix in bone from WT mice (Fig. 4, IE and  IF) . Similar data were observed in DKO mice at the weaning period (4 wk old; Fig. 4II ). The femoral bone histomorphometric parameters were the same in the 12-wk-old WT, Npt2a KO, and Npt2a
Ϫ/Ϫ mice were similar except for a tendency toward increased bone volume/tissue volume in Npt2a KO mice (Table 1) . DKO mice showed significantly increased osteoid volume/bone volume, osteoid volume/bone surface, and osteoid thickness compared with other groups. In contrast, mineral apposition rate, mineralizing surface/bone surface, and bone formation rate/bone surface were significantly decreased in DKO mice compared with the other mice groups. Thus, from the perspective of bone histomorphometry, only the DKO mice exhibited the typical features of advanced rickets. There were no obvious differences in bone analysis between Npt2a ϩ/ϩ Npt2c Ϫ/Ϫ mice and Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice (data not shown).
High-phosphate diet rescues the rickets in DKO mice. Plasma P i levels were significantly increased and Ca levels were significantly decreased in DKO mice fed a high-P i diet (1.2% P i ) after weaning (from 3 to 12 wk old) when compared with mice fed a control P i diet (Fig. 5, A and B) . A high-P i diet prevented the appearance of rickets via correction of the mineralization defect at the levels of growth plate of DKO mice (Fig. 5, C to F) .
DISCUSSION
We do not fully understand whether the renal P i wasting due to a defect of the Na/P i transporter is directly linked to bone disorders. The present study demonstrated that DKO mice developed severe hypophosphatemia (50% reduction) and rick- ets. This phenotype is similar to that seen in HHRH, which is characterized by hypophosphatemia, short stature, rickets and/or osteomalacia, and secondary absorptive hypercalciuria (6, 23, 24) . Studies in DKO animals showed that expansion of the late hypertrophic zone, which is a characteristic feature of rickets, may be secondary to impaired apoptosis of these cells. A high-P i diet rescued DKO from the bone abnormalities, consistent with observations from a previous report that a high-P i diet can reverse of the rickets/osteomalacia in HHRH patients (24) . Sabbagh and co-workers (14) suggested that circulating phosphate is a key determinant of hypertrophic chondrocyte apoptosis in vivo. In addition, injection of FGF23/ PTH causes simultaneous reduction of Npt2a and Npt2c protein levels (8, 18, 20) . In Hyp mice, which develop hypophosphatemic rickets, Npt2a and Npt2c protein levels decreased simultaneously (22) . In this context, the function of Npt2a and Npt2c may be necessary for the control of normal bone development.
It is not clear why mutations in the Npt2c gene produce different phenotypes when comparing humans (NPT2c) and mice (Npt2c). One possibility is that NPT2c function predominates in humans, while Npt2a function predominates in mice. Npt2aKO . WT, n ϭ 7; Npt2aKO, n ϭ 5; DKO, n ϭ 5. In a previous study, the marked differences in phenotypes of the Npt2a and Npt2c knockout mice may result from the differential dominance in transporters for P i homeostasis (19) . Npt2c Ϫ/Ϫ mice showed hypercalciuria and high levels of plasma 1,25(OH) 2 D 3 but not hypophosphatemia and hyperphosphaturia (19) . Na ϩ -dependent P i transport activity in BBMVs was not significantly decreased in Npt2c Ϫ/Ϫ mice (19) . In contrast, Npt2a
Ϫ/Ϫ mice showed hypophosphatemia and reduction of renal Na ϩ -dependent P i transport activity (1). Moreover, Npt2c protein level is increased in renal BBMV of Npt2a Ϫ/Ϫ mice, but the converse does not occur in Npt2c knockout mice (19, 22) . Therefore, we speculate that Npt2c may be involved in calcium/vitamin D system and be linked in a minor way to Na ϩ -dependent P i transport in the renal proximal tubule of mice, but NPT2c may be involved in both pathways (calcium/vitamin D and phosphate transport) in humans.
Another possible explanation for this phenomenon is that NPT2c is involved in bone mineralization. Although Npt2c mRNA was detected in osteoblasts, we failed to detect Npt2c protein in mouse primary osteoblasts and human bone (data not shown). Further studies are needed to clarify the role of Npt2c in P i metabolism in human and rodents.
Previous reports indicate that deletion and missense mutations in the NPT2c molecule lead to more loss-of-function mutations but not the dominant effects found in patients with other mutations (2, 10, 11, 25) . We characterized the phenotype of Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice. Npt2a ϩ/Ϫ mice exhibit a 50% decrease in renal Npt2a mRNA levels relative to WT mice, whereas both renal BBM Npt2a protein levels and Na/P i transport activity are reportedly normal in Npt2a ϩ/Ϫ mice (21). These previous findings indicated that Npt2a ϩ/Ϫ mice exhibit appropriate adaptive upregulation of Npt2a protein in response to the loss of one Npt2a allele (21) . In the present study, Npt2a ϩ/Ϫ Npt2c Ϫ/Ϫ mice showed phenotypes similar (renal P i transport and bone) to those of Npt2a ϩ/ϩ
Npt2c
Ϫ/Ϫ mice. The present data thus suggest that the loss of one Npt2a allele in Npt2c Ϫ/Ϫ mice could compensate for change in Npt2a protein levels and Na/P i transport activity. The mechanisms behind this partial compensatory ability of NPT2a with the loss of NPT2c in subjects affected by HHRH, however, remain unknown.
In conclusion, the present study demonstrated that Npt2a and Npt2c are expressed in mouse kidney in a time-specific manner and act to regulate P i homeostasis and skeletal development in rodents. Thus, the severity of the mineralization abnormalities may be determined by the degree of the hypophosphatemia resulting from defects in Npt2a and Npt2c.
